As nouns the difference between invasive and efungumab

is that invasive is an invasive organism, as, a plant or animal while efungumab is a human monoclonal antibody intended to treat invasive candida infection in combination with amphotericin b.

As an adjective invasive

is that invades a foreign country using military force.

As an adjective candida

is .

As a noun efungumab is

a human monoclonal antibody intended to treat invasive candida infection in combination with amphotericin b.

As nouns the difference between immunosuppressive and dorlixizumab

is that immunosuppressive is (pharmacology) an agent which is capable of immunosuppression while dorlixizumab is a monoclonal antibody used as an immunosuppressive drug.

As an adjective immunosuppressive

is (pharmacology) having the capability to suppress the immune system, capable of immunosuppression.

As nouns the difference between drug and dorlixizumab

is that drug is a substance used to treat an illness, relieve a symptom, or modify a chemical process in the body for a specific purpose while dorlixizumab is a monoclonal antibody used as an immunosuppressive drug.

As a verb drug

is to administer intoxicating drugs to, generally without the recipient's knowledge or consent.

As nouns the difference between mouse and detumomab

is that mouse is any small rodent of the genus mus while detumomab is a mouse monoclonal antibody developed for the treatment of cancer.

As a verb mouse

is to move cautiously or furtively, in the manner of a mouse (the rodent) (frequently used in the phrasal verb to mouse around ).

As nouns the difference between cancer and detumomab

is that cancer is cancer while detumomab is a mouse monoclonal antibody developed for the treatment of cancer.

As an adjective chimeric

is like a chimera.

As a noun ecromeximab is

a chimeric monoclonal antibody being developed for the treatment of malignant melanoma.

As nouns the difference between rejection and daclizumab

is that rejection is the act of rejecting while daclizumab is a humanized monoclonal antibody used to prevent rejection in organ transplantation, especially in kidney transplants.

As nouns the difference between organ and daclizumab

is that organ is organ while daclizumab is a humanized monoclonal antibody used to prevent rejection in organ transplantation, especially in kidney transplants.

As nouns the difference between transplantation and daclizumab

is that transplantation is the resettlement of a group of people while daclizumab is a humanized monoclonal antibody used to prevent rejection in organ transplantation, especially in kidney transplants.